Mar 27 |
Syros Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Corporate Update
|
Mar 27 |
Earnings Scheduled For March 27, 2024
|
Mar 26 |
Syros Pharmaceuticals Q4 2023 Earnings Preview
|
Mar 25 |
Syros Announces Completion of Enrollment of 190 Patients Necessary to Support Primary Endpoint Analysis in SELECT-MDS-1 Phase 3 Trial
|
Mar 20 |
Syros to Report Fourth Quarter and Full Year 2023 Financial Results on Wednesday, March 27, 2024
|
Feb 27 |
Syros to Participate in TD Cowen 44th Annual Health Care Conference
|
Feb 27 |
Investors in Syros Pharmaceuticals (NASDAQ:SYRS) have seen respectable returns of 99% over the past year
|
Jan 31 |
3 Once-in-a-Lifetime Penny Stocks With Unprecedented Surge Potential
|